Monday, July 08, 2024 12:47:45 PM
https://pluri-biotech.com/wp-content/uploads/2024/07/Pluri-PPT-investor_Q2_July_2024-final.pdf
Recent PLUR News
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 11:30:34 AM
- Pluri’s CDMO Selected to Manufacture Kadimastem’s Novel Cell Therapy Product Candidates • GlobeNewswire Inc. • 07/18/2024 06:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 11:30:21 AM
- Pluri Announces €1 Million Proof of Concept Agreement to Enhance Global Sustainable Vegetable Supply • GlobeNewswire Inc. • 07/08/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/18/2024 11:00:32 AM
- Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges • GlobeNewswire Inc. • 06/18/2024 10:30:00 AM
- U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri’s PLX-R18 Acute Radiation Syndrome Contract • GlobeNewswire Inc. • 06/06/2024 10:45:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/31/2024 08:05:18 PM
- Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale • GlobeNewswire Inc. • 05/20/2024 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/09/2024 08:13:36 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 05/09/2024 08:10:54 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:00:37 PM
- Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method • GlobeNewswire Inc. • 04/08/2024 11:00:00 AM
- Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences • GlobeNewswire Inc. • 03/28/2024 11:15:00 AM
- Pluri Inc. Announces 1-for-8 Reverse Share Split • GlobeNewswire Inc. • 03/27/2024 11:00:00 AM
- Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report • GlobeNewswire Inc. • 03/21/2024 11:00:00 AM
- Engage with Pluri's Talent: Exciting Conference Appearances Ahead • GlobeNewswire Inc. • 03/19/2024 08:00:00 AM
- Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing • GlobeNewswire Inc. • 03/14/2024 11:00:00 AM
- Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation • GlobeNewswire Inc. • 03/11/2024 11:00:00 AM
- Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board • GlobeNewswire Inc. • 03/06/2024 12:00:00 PM
- Pluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals • GlobeNewswire Inc. • 02/28/2024 12:00:00 PM
- Form SCHEDULE 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 10:43:05 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 09:34:49 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2024 09:01:45 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM